Park Perspective - Verso Biosense

Verso Biosense will be sharing an insight into their early-stage med tech company, focusing on monitoring the uterus.

To mark international womens Day 2026, Verso Biosense will be sharing an insight into their early-stage med tech company, focusing on monitoring the uterine environment in the female body, based here at Milton Park.

On Thursday 5 March, from 8:30–9:30am, join CEO Kate Rowley for a candid discussion sharing key insights into to Verso Biosense, where they began, what we are doing today, and their vision for the future. Kate will also share opportunities to engage with their work and explore areas where meaningful collaboration is possible.

About our Speaker: Kate has an exceptionally broad experience garnered from a variety of roles spanning researcher to board member over her 30-year history in the healthcare sector.

Following success as a post-doctoral researcher in viral technologies, she started her journey in commercialization of science at the Scottish Association for Marine Science, leading on IP, licensing, commercial services and managing the business Incubator co-located with the research institute. She has spent much of her life sciences career in commercial executive roles leading business development and M&A activities in the health tech arena.

Kate has been an engaged investor and non-exec board member, chairing sub committees, and leading VC investment rounds from university spin outs though to growth stage companies. As well as a first-class honors degree in Biotechnology, Kate holds a PhD from the University of Reading and an MBA from the University of Glasgow.